Cargando…
In Reply
Autores principales: | Brennen, W. Nathaniel, Schweizer, Michael T., Wang, Hao, Bivalacqua, Trinity J., Partin, Alan W., Lim, Su Jin, Chapman, Carolyn, Abdallah, Rehab, Levy, Oren, Bhowmick, Neil A., Karp, Jeffrey M., De Marzo, Angelo, Isaacs, John T., Denmeade, Samuel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591553/ https://www.ncbi.nlm.nih.gov/pubmed/30925030 http://dx.doi.org/10.1002/sctm.19-0068 |
Ejemplares similares
-
A Phase I Study to Assess the Safety and Cancer‐Homing Ability of Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer
por: Schweizer, Michael T., et al.
Publicado: (2019) -
Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer
por: Brennen, W. Nathaniel, et al.
Publicado: (2012) -
Albumin-linked prostate-specific antigen-activated thapsigargin- and niclosamide-based molecular grenades targeting the microenvironment in metastatic castration-resistant prostate cancer
por: Akinboye, Emmanuel S., et al.
Publicado: (2019) -
Mipsagargin: The Beginning—Not the End—of Thapsigargin Prodrug-Based Cancer Therapeutics
por: Isaacs, John T., et al.
Publicado: (2021) -
Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate
por: Brennen, W. Nathaniel, et al.
Publicado: (2017)